Nantahala Capital Management »

Acelrx Pharmaceuticals shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Acelrx Pharmaceuticals (TLPH) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Acelrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acelrx Pharmaceuticals held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelrx Pharmaceuticals by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.8M 2.0M 0.89
2024-03-31 $2.1M 2.0M 1.03
2023-12-31 $1.5M 2.0M 0.74
2023-09-30 $1.1M 1.9M 0.58

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Eli Lilly & Co. Put Option (LLY)
Eli Lilly & Co. Put Option (LLY)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Spdr Ser Tr S&p Biotech (XBI)
Spdr Ser Tr S&p Biotech (XBI)
Peloton Interactive Cl A Com (PTON)
Peloton Interactive Cl A Com (PTON)
Grand Canyon Education Put Option (LOPE)
Grand Canyon Education Put Option (LOPE)
Imax Corp Cad (IMAX)

View all positions for Nantahala Capital Management

Top funds holding Acelrx Pharmaceuticals

Nantahala Capital Management
Rosalind Advisors
Rock Springs Capital Management
MAI Wealth Advisors
Vanguard Group
Royal Bank of Canada
Geode Capital Management
Values First Advisors
BlackRock
Susquehanna International
Turtle Creek Wealth Advisors
Two Sigma Securities
Citadel Advisors
State Street Corporation
Tower Research Capital

View all funds holding Acelrx Pharmaceuticals